Conversely, our results show serum IL-23 was not differentially modulated in patients with favorable and unfavorable TB treatment outcome, suggesting that response mediated by TH17 cells was not affected and, therefore, that the differential production of IL-17 is derived from another axis. Here, IL17A is linked to tuberculosis.